Prostate Cancer Patients Can Improve Bone Health With Osteoporosis Medications

Men with non-metastatic prostate cancer who receive androgen deprivation therapy risk loss of bone mineral density and fractures, but both bisphosphonates and denosumab can improve their bone health.

Source: CancerNetwork - August 8, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: Genitourinary Cancers News Prostate Cancer Source Type: news